- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Canaccord Drops $6 Million In Cedara's Stocking
Cedara Software has closed a private placement with Canaccord Capital for $6.15 million. The Canadian imaging software firm plans to use the proceeds to finance its operations and the operations of its subsidiaries and to satisfy the payment and interest
Cedara Software has closed a private placement with Canaccord Capital for $6.15 million. The Canadian imaging software firm plans to use the proceeds to finance its operations and the operations of its subsidiaries and to satisfy the payment and interest deferred from Sept. 30 to former owners of Dicomit, acquired in mid-2000. In addition, Cedara will be able to raise another $3.1 million by selling shares in its Surgical Navigation Specialists (SNS) business to the investing lenders. This move will give the investors a maximum 6% interest in SNS.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
